Advertisement
Loading...

Invesco Biotechnology & Genome ETF

PBE•AMEX
Financial Services
Asset Management
$82.15
$0.10(0.12%)
U.S. Market opens in 1h 34m
Advertisement

Invesco Biotechnology & Genome ETF (PBE) Stock Overview

Explore Invesco Biotechnology & Genome ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap247.4M
P/E RatioN/A
EPS (TTM)$4.24
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$76.39
3 Months$85.69
1 Year Target$85.14

PBE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Invesco Biotechnology & Genome ETF (PBE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $85.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 247.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.12%
5-Day Change
1.18%
1-Month Change
2.92%
3-Month Change
0.69%
6-Month Change
-0.82%
Year-to-Date (YTD) Change
-0.00%
1-Year Change
30.46%
3-Year Change
34.96%
5-Year Change
14.06%
All-Time (Max) Change
457.70%

Contact Information

https://www.invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html
1-800-983-0903
11 Greenway Plaza, Suite 1000, Houston, TX, 77046

Company Facts

IPO DateJun 23, 2005
CountryUS
Actively Trading

Frequently Asked Questions